Literature DB >> 6299319

Radioprotection by WR-2721 in vitro at low oxygen tensions: implications for its mechanisms of action.

R E Durand.   

Abstract

Radioprotection of spheroids of Chinese hamster V79 cells by WR-2721 was found to be a function of spheroid size, with the greatest dose-modifying effect by the protector observed for spheroids almost large enough to contain radioresistant "anoxic" cells. The nature of the response suggested that most of the protective effect was due to the presence of an increased hypoxic fraction in the drug-treated spheroids. Similarly, when single-cell suspensions were irradiated at various oxygen tensions, one component of radioprotection by WR-2721 was found to be highly dependent upon the available oxygen. Two mechanisms of radioprotection of V79 cells by WR-2721 were thus demonstrated: a modest, oxygen-independent effect, presumably due to hydrogen donation, and an oxygen-depleting effect, which is of maximal significance for cells or tissues which would otherwise be partially sensitized by low levels of oxygen.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6299319      PMCID: PMC2011303          DOI: 10.1038/bjc.1983.58

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  15 in total

1.  A comparative study of the radioprotective effects of cysteamine, WR-2721, and WR-1065 in cultured human cells.

Authors:  J W Purdie
Journal:  Radiat Res       Date:  1979-02       Impact factor: 2.841

2.  Distribution of 35S-labeled WR-2721 in normal and malignant tissues of the mouse1,2.

Authors:  J F Utley; C Marlowe; W J Waddell
Journal:  Radiat Res       Date:  1976-11       Impact factor: 2.841

Review 3.  Quantitation of the radiotherapeutic importance of naturally-hypoxic normal tissues from collated experiments with rodents using single doses.

Authors:  J H Hendry
Journal:  Int J Radiat Oncol Biol Phys       Date:  1979-07       Impact factor: 7.038

Review 4.  Mammalian cell studies with diamide.

Authors:  J W Harris
Journal:  Pharmacol Ther       Date:  1979       Impact factor: 12.310

5.  Radiobiolgoical and biochemical studies of thiophosphate radioprotective compounds related to cysteamine.

Authors:  J W Harris; T L Phillips
Journal:  Radiat Res       Date:  1971-05       Impact factor: 2.841

6.  Variable radiobiological responses of spheroids.

Authors:  R E Durand
Journal:  Radiat Res       Date:  1980-01       Impact factor: 2.841

7.  Radiation response of multicell spheroids--an in vitro tumour model.

Authors:  R M Sutherland; R E Durand
Journal:  Curr Top Radiat Res Q       Date:  1976-01

8.  Rationale for initial clinical trials and future development of radioprotectors.

Authors:  T L Phillips
Journal:  Cancer Clin Trials       Date:  1980

9.  Active versus passive absorption kinetics as the basis for selective protection of normal tissues by S-2-(3-aminopropylamino)-ethylphosphorothioic acid.

Authors:  J M Yuhas
Journal:  Cancer Res       Date:  1980-05       Impact factor: 12.701

10.  In vitro evaluation of some latent radioprotective compounds.

Authors:  O Vos; L Budke; G A Grant
Journal:  Int J Radiat Biol Relat Stud Phys Chem Med       Date:  1976-11
View more
  9 in total

1.  Radiation-induced chronic oxidative renal damage can be reduced by amifostine.

Authors:  Rusen Cosar; Vuslat Yurut-Caloglu; Sevgi Eskiocak; Alaattin Ozen; Semsi Altaner; Kamuran Ibis; Nesrin Turan; Bengu Denizli; Cem Uzal; Mert Saynak; Sule Parlar; Murat Caloglu; Burcu Uregen; Zafer Kocak
Journal:  Med Oncol       Date:  2011-02-24       Impact factor: 3.064

2.  Erythrophagocytosis induces heat shock protein synthesis by human monocytes-macrophages.

Authors:  M Clerget; B S Polla
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

3.  Zebrafish as a model system to screen radiation modifiers.

Authors:  Misun Hwang; Cha Yong; Luigi Moretti; Bo Lu
Journal:  Curr Genomics       Date:  2007-09       Impact factor: 2.236

4.  Inhibition of parathyroid hormone secretion and parathyroid hormone-independent diminution of tubular calcium reabsorption by WR-2721, a unique hypocalcemic agent.

Authors:  S Hirschel-Scholz; J Caverzasio; J P Bonjour
Journal:  J Clin Invest       Date:  1985-11       Impact factor: 14.808

Review 5.  Amifostine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential as a radioprotector and cytotoxic chemoprotector.

Authors:  C M Spencer; K L Goa
Journal:  Drugs       Date:  1995-12       Impact factor: 9.546

6.  Evaluation of protective effect of amifostine on dacarbazine induced genotoxicity.

Authors:  M Etebari; A Jafarian-Dehkordi; V Lame
Journal:  Res Pharm Sci       Date:  2015 Jan-Feb

7.  Radioprotective effects of cimetidine on rats irradiated by long-term, low-dose-rate neutrons and 60Co γ-rays.

Authors:  Ding-Wen Jiang; Qing-Rong Wang; Xian-Rong Shen; Ying He; Tian-Tian Qian; Qiong Liu; Deng-Yong Hou; Yu-Ming Liu; Wei Chen; Xin Ren; Ke-Xian Li
Journal:  Mil Med Res       Date:  2017-02-27

8.  Radiosensitisation and radioprotection by BSO and WR-2721: the role of oxygenation.

Authors:  R E Durand; P L Olive
Journal:  Br J Cancer       Date:  1989-10       Impact factor: 7.640

9.  The effect of 2-[(aminopropyl)amino] ethanethiol (WR-1065) on radiation induced DNA double strand damage and repair in V79 cells.

Authors:  C P Sigdestad; S H Treacy; L A Knapp; D J Grdina
Journal:  Br J Cancer       Date:  1987-05       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.